How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?

Ann Oncol. 2008 Jun;19(6):1203. doi: 10.1093/annonc/mdn152. Epub 2008 Mar 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anthracyclines / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / secondary
  • Female
  • Humans
  • Receptor, ErbB-2 / biosynthesis*

Substances

  • Anthracyclines
  • Receptor, ErbB-2